Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Westlake Chemical Partners (WLKP) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Westlake Chemical Partners (WLKP) over the last 13 years, with Q3 2025 value amounting to -$854000.0.

  • Westlake Chemical Partners' Change in Accured Expenses rose 2114.5% to -$854000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $12.8 million, marking a year-over-year increase of 27228.33%. This contributed to the annual value of -$5.8 million for FY2024, which is 24458.52% down from last year.
  • As of Q3 2025, Westlake Chemical Partners' Change in Accured Expenses stood at -$854000.0, which was up 2114.5% from -$28.3 million recorded in Q2 2025.
  • In the past 5 years, Westlake Chemical Partners' Change in Accured Expenses ranged from a high of $45.9 million in Q1 2025 and a low of -$35.4 million during Q1 2022
  • Moreover, its 5-year median value for Change in Accured Expenses was -$854000.0 (2025), whereas its average is $788526.3.
  • Per our database at Business Quant, Westlake Chemical Partners' Change in Accured Expenses surged by 1226642.34% in 2021 and then plummeted by 495836.91% in 2022.
  • Westlake Chemical Partners' Change in Accured Expenses (Quarter) stood at $33.9 million in 2021, then plummeted by 115.37% to -$5.2 million in 2022, then dropped by 6.15% to -$5.5 million in 2023, then rose by 29.55% to -$3.9 million in 2024, then skyrocketed by 78.07% to -$854000.0 in 2025.
  • Its Change in Accured Expenses stands at -$854000.0 for Q3 2025, versus -$28.3 million for Q2 2025 and $45.9 million for Q1 2025.